Gastrointestinal symptoms in COVID-19

Konrad Lewandowski; Magdalena Kaniewska; Mariusz Rosołowski; Grażyna Rydzewska

doi:10.5114/pg.2021.112683

Gastrointestinal symptoms in COVID-19

Prz Gastroenterol. 2023;18(1):61-66. doi: 10.5114/pg.2021.112683. Epub 2022 Jan 18.

Authors

Konrad Lewandowski¹, Magdalena Kaniewska¹, Mariusz Rosołowski^{2

3}, Grażyna Rydzewska^{1

4}

Affiliations

¹ Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of Ministry of Inferior and Administration, Warsaw, Poland.
² Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland.
³ Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, Bialystok, Poland.
⁴ Collegium Medicum, Jan Kochanowski University, Kielce, Poland.

Abstract

SARS-CoV-2 infection manifests mainly by involving the respiratory system. Due to the presence of abdominal symptoms, the digestive system is clearly involved in the expression, transmission, and possible pathogenesis of COVID-19. There are many theories regarding the development of abdominal symptoms, including angiotensin 2 receptor, cytokine storm, and disturbances of the intestinal microbiome. This paper provides an overview of the most important meta-analyses and publications on gastrointestinal symptoms and the gut microbiome in COVID-19.

Keywords: COVID-19; SARS-CoV-2; gastrointestinal symptoms; gut microbiota.

Publication types

Review